RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer
Rui Wang , Haichuan Hu , Yunjian Pan , Yuan Li
Journal of Clinical Oncology 30 ( 35) 4352 -4359
548
2012
Tissue-Specific Immunoregulation: A Call for Better Understanding of the “Immunostat” in the Context of Cancer
William Pao , Chia-Huey Ooi , Fabian Birzele , Astrid Ruefli-Brasse
Cancer Discovery 8 ( 4) 395 -402
32
2018
Characterizing the cancer genome in lung adenocarcinoma
Gad Getz , Sven Perner , Li Ding , Rameen Beroukhim
Nature 450 ( 7171) 893 -898
1,238
2007
The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells
Shannon M Mumenthaler , Jasmine Foo , Nathan C Choi , Nicholas Heise
Cancer Informatics 14 19 -31
56
2015
Catalyzing the field of precision oncology, one basket at a time.
William Pao , Imola Fodor
Nature Medicine 24 ( 4) 387 -388
3
2018
Chipping away at the lung cancer genome
William Pao , Katherine E Hutchinson
Nature Medicine 18 ( 3) 349 -351
169
2012
Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer
Christine M Lovly , Nerina T McDonald , Heidi Chen , Sandra Ortiz-Cuaran
Nature Medicine 20 ( 9) 1027 -1034
262
2014
Anchored multiplex PCR for targeted next-generation sequencing
Zongli Zheng , Matthew Liebers , Boryana Zhelyazkova , Yi Cao
Nature Medicine 20 ( 12) 1479 -1484
729
2014
Facilitating a culture of responsible and effective sharing of cancer genome data.
Lillian L Siu , Mark Lawler , David Haussler , Bartha Maria Knoppers
Nature Medicine 22 ( 5) 464 -471
58
2016
Use of Epidermal Growth Factor Receptor/Kirsten Rat Sarcoma 2 Viral Oncogene Homolog Mutation Testing to Define Clonal Relationships Among Multiple Lung Adenocarcinomas : Comparison With Clinical Guidelines
Nicolas Girard , Charuhas Deshpande , Christopher G. Azzoli , Valerie W. Rusch
Chest 137 ( 1) 46 -52
91
2010
T Cell Receptor, γδ
Adrian Hayday , William Pao
Encyclopedia of Immunology (Second Edition) 2268 -2278
7
1998
Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel
Douglas B. Johnson , Kimberly H. Dahlman , Jared Knol , Jill Gilbert
Oncologist 19 ( 6) 616 -622
70
2014
MET Exon 14 Skipping in Non-Small Cell Lung Cancer
Rebecca S. Heist , Hyo Sup Shim , Shalini Gingipally , Mari Mino‐Kenudson
Oncologist 21 ( 4) 481 -486
103
2016
PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR
Martin L. Sos , Mirjam Koker , Barbara A. Weir , Stefanie Heynck
Cancer Research 69 ( 8) 3256 -3261
619
2009
Genetic predictors of MEK-dependence in non-small cell lung cancer
Christine A. Pratilas , Aphrothiti J. Hanrahan , Ensar Halilovic , Yogindra Persaud
Cancer Research 68 ( 22) 9375 -9383
213
2008
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas
Sizhi Paul Gao , Kevin G. Mark , Kenneth Leslie , William Pao
Journal of Clinical Investigation 117 ( 12) 3846 -3856
533
2007
NGS catalog: A database of next generation sequencing studies in humans
Junfeng Xia , Qingguo Wang , Peilin Jia , Bing Wang
Human Mutation 33 ( 6)
31
2012
A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer
Zengliu Su , Dora Dias-Santagata , MarKeesa Duke , Katherine Hutchinson
The Journal of Molecular Diagnostics 13 ( 1) 74 -84
164
2011
Abstract 2101A: CNX-2006, a novel irreversible epidermal growth factor receptor (EGFR) inhibitor, selectively inhibits EGFR T790M and fails to induce T790M-mediated resistancein vitro.
Kadoaki Ohashi , Kenichi Suda , Jing Sun , Yumei Pan
Cancer Research 73
7
2013
Consensus Rules in Variant Detection from Next-Generation Sequencing Data
Peilin Jia , Fei Li , Jufeng Xia , Haiquan Chen
PLOS ONE 7 ( 6)
30
2012